CYduct Diagnostics(CYDX)
$0.910.00 (0.00%)
CYDX
CYduct Diagnostics financials statements
$0.91
At close:0.00 (0.00%)
CYduct Diagnostics (CYDX) Ratios
10 Followers
CYduct Diagnostics Ratios
CYDX's free cash flow for Q1 2026 was $430.00. For the 2026 fiscal year, CYDX's free cash flow was increased by $0.00 and operating cash flow was $432.00. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.07 | 0.02 | 0.03 | 0.04 | 0.21 |
| Quick Ratio | 0.04 | 0.01 | 0.02 | 0.04 | 0.20 |
| Cash Ratio | 0.02 | 0.00 | 0.02 | 0.03 | 0.19 |
| Solvency Ratio | -0.19 | -0.15 | -0.17 | -0.12 | -0.10 |
| Operating Cash Flow Ratio | 0.03 | -0.03 | -0.09 | -0.15 | -0.09 |
| Short-Term Operating Cash Flow Coverage | 0.14 | -0.84 | -2.19 | -0.95 | -1.60 |
| Net Current Asset Value | $ -1.06M | $ -2.81M | $ -2.40M | $ -2.02M | $ -1.55M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 23.58 | 18.93 | 12.24 | 7.05 | 1.75 |
| Debt-to-Equity Ratio | -0.67 | -0.25 | -0.28 | -0.28 | -0.34 |
| Debt-to-Capital Ratio | -2.04 | -0.34 | -0.39 | -0.39 | -0.50 |
| Long-Term Debt-to-Capital Ratio | -1.47 | -0.29 | -0.33 | -0.17 | -0.40 |
| Financial Leverage Ratio | -0.03 | -0.01 | -0.02 | -0.04 | -0.19 |
| Debt Service Coverage Ratio | -1.17 | -2.67 | -3.18 | -1.42 | -1.72 |
| Interest Coverage Ratio | -2.95 | -7.21 | -9.68 | -14.12 | -23.82 |
| Debt to Market Cap | 0.30 | 0.54 | 0.25 | 0.25 | 0.40 |
| Interest Debt Per Share | 0.14 | 0.15 | 0.14 | 0.12 | 0.10 |
| Net Debt to EBITDA | -4.52 | -1.96 | -1.69 | -1.17 | -1.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.32% | 66.19% | 66.99% | 69.89% | 67.53% |
| EBIT Margin | -220.10% | -513.84% | -448.49% | -372.59% | -429.06% |
| EBITDA Margin | -220.10% | -513.84% | -448.49% | -369.75% | -177.55% |
| Operating Profit Margin | -220.10% | -513.84% | -448.49% | -372.59% | -429.06% |
| Pretax Profit Margin | -294.73% | -585.13% | -494.81% | -398.98% | -447.08% |
| Net Profit Margin | -294.73% | -585.13% | -494.81% | -396.13% | -447.08% |
| Continuous Operations Profit Margin | -294.73% | -585.13% | -494.81% | -398.98% | -447.08% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 99.29% | 100.00% |
| EBT Per EBIT | 133.91% | 113.88% | 110.33% | 107.08% | 104.20% |
| Return on Assets (ROA) | -690.85% | -1097.70% | -763.56% | -584.72% | -141.74% |
| Return on Equity (ROE) | 19.66% | 14.73% | 17.45% | 23.36% | 27.12% |
| Return on Capital Employed (ROCE) | 36.26% | 16.66% | 20.99% | 25.65% | 36.33% |
| Return on Invested Capital (ROIC) | 44.61% | 17.33% | 21.96% | 30.59% | 39.15% |
| Return on Tangible Assets | -690.85% | -1097.70% | -763.56% | -584.72% | -141.74% |
| Earnings Yield | -8.90% | -31.31% | -15.33% | -20.43% | -32.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.71 | 3.78 | 6.62 | 10.33 | 12.30 |
| Payables Turnover | 0.10 | 0.11 | 0.24 | 0.52 | 0.02 |
| Inventory Turnover | 2.53 | 1.34 | 2.29 | 2.48 | 1.83 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 2.34 | 1.88 | 1.54 | 1.48 | 0.32 |
| Working Capital Turnover Ratio | -0.05 | -0.04 | -0.05 | -0.08 | -0.09 |
| Cash Conversion Cycle | -3296.22 | -2851.70 | -1311.69 | -525.20 | -15633.70 |
| Days of Sales Outstanding | 63.88 | 96.57 | 55.11 | 35.34 | 29.68 |
| Days of Inventory Outstanding | 144.39 | 271.40 | 159.53 | 146.95 | 199.15 |
| Days of Payables Outstanding | 3504.48 | 3219.67 | 1526.33 | 707.49 | 15862.53 |
| Operating Cycle | 208.27 | 367.97 | 214.64 | 182.29 | 228.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.01 | -0.03 | -0.05 | -0.02 |
| Free Cash Flow Per Share | 0.00 | -0.01 | -0.03 | -0.05 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 2299.00 | 0.00 | -58277.67 | -66713.50 | -42577.67 |
| Capital Expenditure Coverage Ratio | 2299.00 | 0.00 | -58277.67 | -66713.50 | -42577.67 |
| Operating Cash Flow Coverage Ratio | 0.02 | -0.10 | -0.26 | -0.47 | -0.25 |
| Operating Cash Flow to Sales Ratio | 0.16 | -1.02 | -2.07 | -2.24 | -1.36 |
| Free Cash Flow Yield | 0.49% | -5.45% | -6.41% | -11.53% | -9.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -11.23 | -3.20 | -6.52 | -4.90 | -3.06 |
| Price-to-Sales (P/S) Ratio | 33.13 | 18.69 | 32.28 | 19.39 | 13.67 |
| Price-to-Book (P/B) Ratio | -2.21 | -0.47 | -1.14 | -1.14 | -0.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 202.73 | -18.36 | -15.60 | -8.67 | -10.07 |
| Price-to-Operating Cash Flow Ratio | 202.81 | -18.36 | -15.60 | -8.67 | -10.07 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | 1.83 | 0.49 | -0.37 | -0.31 |
| Enterprise Value Multiple | -19.58 | -5.60 | -8.89 | -6.41 | -9.19 |
| Enterprise Value | 3.03M | 2.03M | 3.37M | 2.83M | 1.53M |
| EV to EBITDA | -19.58 | -5.60 | -8.89 | -6.41 | -9.19 |
| EV to Sales | 43.09 | 28.77 | 39.86 | 23.71 | 16.31 |
| EV to Free Cash Flow | 263.65 | -28.25 | -19.26 | -10.60 | -12.01 |
| EV to Operating Cash Flow | 263.77 | -28.25 | -19.26 | -10.60 | -12.01 |
| Tangible Book Value Per Share | -0.19 | -0.54 | -0.46 | -0.39 | -0.30 |
| Shareholders’ Equity Per Share | -0.19 | -0.54 | -0.46 | -0.39 | -0.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Net Income Per Share | -0.04 | -0.08 | -0.08 | -0.09 | -0.08 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.34 | 1.14 | 1.10 | 1.07 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.82 | 5.80 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.06 | 0.17 | 0.42 | 0.56 | 0.30 |
Currency in USD
